SEP 27, 2018 5:38 AM PDT

A New Science Center For Brain Research

Neuroscientists all over the globe are actively looking for more effective treatments for Alzheimer's disease, but it hasn't been a very productive endeavor for most. Pfizer, once at the forefront of research into the condition has halted all of their clinical trials and will not continue to fund research for Alzheimer's.

At Arizona State University, however, their BioDesign center is poised to take on neurological degenerative diseases like Alzheimer's, Parkinson's and vascular dementia with the recent opening of the ASU-Banner Neurodegenerative Disease Research Center. The plan is to conduct cutting-edge research into brain illnesses and injuries as well as cognitive decline and the social impact the growing numbers of Alzheimer's patients will have. The numbers are a clear indication that research is desperately needed. The World Health Organization (WHO) and the Centers for Disease Control (CDC) put the number at 15 million patients in the United States. Globally, cases are hovering at more than 44 million, and those numbers are rising steadily. Experts predict that as the world population ages, there could be 115 million people worldwide living with dementia.

RELATED: Herpes And Alzheimer's

Eric Reiman is the executive director of Banner Alzheimer's Institute. He told the East Valley Tribune, "We would like to create a destination center for the discovery of a broader portfolio of promising ways to treat and indeed prevent Alzheimer's disease. We want to leverage strengths that we will generate here with complementary resources throughout the state to have the most impactful difference. Ninety-nine-point-eight percent of Alzheimer's treatments found in the last 12 years that have been discovered through traditional research mechanisms have failed to work. We're emphasizing a strategy that fosters close working relationships between researchers who study human beings with and without these disorders, along with experimental researchers who use cellular or small animal models."

The BioDesign Center was built with collaboration in mind. It will house lab space and offices for 80 lead researchers and 400 support staff. The building is 191,000 square feet and laid out like a neighborhood, to encourage researchers from different science fields to interact and collaborate with one another. Joshua LaBaer is the Biodesign Institute's executive director. He explained how the center's floor plan and esthetic would hopefully push researchers into partnering on related work, "It's meant to cause scientists to collide with each other, and that's important because it is in individuals colliding with each other that new ideas emerge."

There are already significant results coming from researchers at the center. In June, a project they were part of, along with scientists at Mount Sinai in New York, found a connection between the herpes virus and Alzheimer's which was a first. Check out the video below to see how this new epicenter of neurological research could move the needle on finding treatments for Alzheimer's

Sources:  CDC,  Arizona State University, East Valley Tribune

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
APR 26, 2020
Plants & Animals
APR 26, 2020
Researchers Observe Vocal Learning in Bats
Bats have garnered oodles of attention in previous weeks as they’ve been identified as potential carriers of the i ...
MAY 08, 2020
Cannabis Sciences
MAY 08, 2020
Why Your Dreams Get More Intense When You Quit Cannabis
Upon quitting cannabis, many notice their dreams become a lot more vivid and intense. But why?  To answer that ques ...
JUN 10, 2020
Neuroscience
JUN 10, 2020
How Parasites Manipulate Your Behavior
Scientists have found examples across the animal kingdom, showing that parasites can manipulate their hosts' behavio ...
JUN 13, 2020
Neuroscience
JUN 13, 2020
High Doses of Ketamine Can Switch Off the Brain
Researchers from the University of Cambridge, England, have found that high doses of ketamine temporarily switch off the ...
JUN 14, 2020
Chemistry & Physics
JUN 14, 2020
Why Are There So Few Black People in STEM?
On June 10th, 2020, thousands of STEM scientists and organizations around the world went on strike to protest systemic r ...
JUL 02, 2020
Cell & Molecular Biology
JUL 02, 2020
The Intricate Movements of a Critical Receptor are Revealed
Scientists have now learned more about a critical protein in the brain called the NMDA receptor, tracking every atom as ...
Loading Comments...